FDA Moves to Reevaluate Several Peptides American Med Spa Association The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA's new guidelines on bulk drug compounding Pharmacy & Healthcare Legal Blog Save Peptides Save Peptides This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides